UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

E.04.02 New targets in generalized anxiety disorder

European neuropsychopharmacology, 2015-09, Vol.25, p.S155-S155

Baldwin, D.S

2015

Link zum Volltext

Verfügbarkeit prüfen

E.02.01 Sexual side effects of antidepressants and lithium

European neuropsychopharmacology, 2014-10, Vol.24, p.S147-S148

Baldwin, D.S

2014

Link zum Volltext

Verfügbarkeit prüfen

S.14.04 Pharmacological treatment of social phobia: efficacy, acceptability and unmet needs

European neuropsychopharmacology, 2012-10, Vol.22, p.S132-S133

Baldwin, D.S

2012

Link zum Volltext

Verfügbarkeit prüfen

Quality of English inpatient mental health services for people with anxiety or depressive disorders: Findings and recommendations from the core audit of the National Clinical Audit of Anxiety and Depression

Comprehensive psychiatry, 2021-01, Vol.104, p.152212-152212, Article 152212

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract # 1866 How is the immune balance affected in patients with generalised anxiety disorder?

Brain, behavior, and immunity, 2016-10, Vol.57, p.e43-e43

2016

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Review of the Predictors of Health Service Utilisation by Adults with Mental Disorders in the UK

European psychiatry, 2015-03, Vol.30, p.221-221

2015

Link zum Volltext

Verfügbarkeit prüfen

P.2.f.020 The efficacy of vortioxetine in treating patients with severe depression or with depression and high level of anxiety symptoms

European neuropsychopharmacology, 2014-10, Vol.24, p.S463-S464

2014

Link zum Volltext

Verfügbarkeit prüfen

Manifesto for a European research network into obsessive-compulsive and related disorders

European neuropsychopharmacology, 2013-07, Vol.23 (7), p.561-568

2013

Link zum Volltext

Verfügbarkeit prüfen

P.4.002 The effect of prefrontal transcranial direct current stimulation (tDCS) on attention network function in healthy humans

European neuropsychopharmacology, 2014-03, Vol.24, p.S82-S82

2014

Link zum Volltext

Verfügbarkeit prüfen

C.20.04 Anxiety disorders treated with an ASRI antidepressant

European neuropsychopharmacology, 2007, Vol.17, p.S611-S612

Baldwin, D.S

2007

Link zum Volltext

Verfügbarkeit prüfen

P.4.a.005 The effects of duloxetine on subjective, autonomic and neurocognitive response to 7.5% carbon dioxide challenge

European neuropsychopharmacology, 2014-10, Vol.24, p.S579-S579

2014

Link zum Volltext

Verfügbarkeit prüfen

P.2.f.021 The safety and tolerability of vortioxetine in treating adults with major depressive disorder after 52 weeks of open-label treatment

European neuropsychopharmacology, 2014-10, Vol.24, p.S464-S464

2014

Link zum Volltext

Verfügbarkeit prüfen

Optimizing outcomes in depression: focus on antidepressant compliance

International clinical psychopharmacology, 2002-11, Vol.17 (6), p.265-271

2002

Link zum Volltext

Verfügbarkeit prüfen

effect of temperature on leaching and subsequent decomposition of dissolved carbon from inundated floodplain litter: implications for the generation of hypoxic blackwater in lowland floodplain rivers

Chemistry and ecology, 2014-08, Vol.30 (6), p.491-500

2014

Link zum Volltext

Verfügbarkeit prüfen

P.3.021 The effects of duloxetine on subjective, autonomic and neurocognitive response to 7.5% carbon dioxide challenge

European neuropsychopharmacology, 2014-03, Vol.24, p.S72-S73

2014

Link zum Volltext

Verfügbarkeit prüfen

P.2.a.007 Lu AA21004, a multimodal psychotropic agent, in the open-label, long-term treatment of major depressive disorder

European neuropsychopharmacology, 2012-10, Vol.22, p.S227-S228

2012

Link zum Volltext

Verfügbarkeit prüfen

P.4.a.003 Prevention of relapse in adult patients with generalised anxiety disorder after response to the multimodal psychotropic agent Lu AA21004

European neuropsychopharmacology, 2012-10, Vol.22, p.S358-S359

2012

Link zum Volltext

Verfügbarkeit prüfen

P.3.014 Using 7.5% CO2 challenge to evaluate novel psychological treatments for anxiety

European neuropsychopharmacology, 2014-03, Vol.24, p.S66-S67

2014

Link zum Volltext

Verfügbarkeit prüfen

E.01.01 Prescribing for unlicensed applications

European neuropsychopharmacology, 2008, Vol.18, p.S199-S199

2008

Link zum Volltext

Verfügbarkeit prüfen

1673 – Evaluation of sleep and pain in newly diagnosed patients with generalised anxiety disorder (GAD): the espiga study

European psychiatry, 2013, Vol.28, p.1-1

2013

Link zum Volltext

Verfügbarkeit prüfen

Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service

Journal of affective disorders, 2009-04, Vol.114 (1), p.305-309

2009

Link zum Volltext

Verfügbarkeit prüfen

Veterinary surgeons and suicide: a structured review of possible influences on increased risk

Veterinary record, 2010-03, Vol.166 (13), p.388-397

2010

Link zum Volltext

Verfügbarkeit prüfen

P.4.a.009 Symptom improvement and functional recovery in patients with anxiety disorders

European neuropsychopharmacology, 2009, Vol.19, p.S590-S591

2009

Link zum Volltext

Verfügbarkeit prüfen

P.4.b.005 Impaired attentional control in high and low anxious healthy volunteers: evidence from the antisaccade task

European neuropsychopharmacology, 2009, Vol.19, p.S599-S599

2009

Link zum Volltext

Verfügbarkeit prüfen

Effects of mindfulness-based interventions on symptoms and interoception in trauma-related disorders and exposure to traumatic events: Systematic review and meta-analysis

Psychiatry research, 2024-06, Vol.336, p.115897-115897, Article 115897

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(90)
Buchkapitel
(12)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(50)
Psychiatry
(42)
Humans
(32)
Internal Medicine
(22)
Pharmacology & Pharmacy
(18)
Female
(14)
Animals
(13)
Biological And Medical Sciences
(13)
Chapter
(13)
Environmental Sciences
(13)
Environmental Sciences & Ecology
(13)
Abnormal Psychology
(12)
Male
(12)
Neurology & Clinical Neurophysiology
(12)
Personal & Public Health
(12)
Physical Sciences
(10)
Medical Sciences
(8)
Technology
(8)
Water Resources
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

E.04.02 New targets in generalized anxiety disorder

E.02.01 Sexual side effects of antidepressants and lithium

S.14.04 Pharmacological treatment of social phobia: efficacy, acceptability and unmet needs

Quality of English inpatient mental health services for people with anxiety or depressive disorders: Findings and recommendations from the core audit of the National Clinical Audit of Anxiety and Depression

Abstract # 1866 How is the immune balance affected in patients with generalised anxiety disorder?

A Systematic Review of the Predictors of Health Service Utilisation by Adults with Mental Disorders in the UK

P.2.f.020 The efficacy of vortioxetine in treating patients with severe depression or with depression and high level of anxiety symptoms

Manifesto for a European research network into obsessive-compulsive and related disorders

P.4.002 The effect of prefrontal transcranial direct current stimulation (tDCS) on attention network function in healthy humans

C.20.04 Anxiety disorders treated with an ASRI antidepressant

P.4.a.005 The effects of duloxetine on subjective, autonomic and neurocognitive response to 7.5% carbon dioxide challenge

P.2.f.021 The safety and tolerability of vortioxetine in treating adults with major depressive disorder after 52 weeks of open-label treatment

Optimizing outcomes in depression: focus on antidepressant compliance

effect of temperature on leaching and subsequent decomposition of dissolved carbon from inundated floodplain litter: implications for the generation of hypoxic blackwater in lowland floodplain rivers

P.3.021 The effects of duloxetine on subjective, autonomic and neurocognitive response to 7.5% carbon dioxide challenge

P.2.a.007 Lu AA21004, a multimodal psychotropic agent, in the open-label, long-term treatment of major depressive disorder

P.4.a.003 Prevention of relapse in adult patients with generalised anxiety disorder after response to the multimodal psychotropic agent Lu AA21004

P.3.014 Using 7.5% CO2 challenge to evaluate novel psychological treatments for anxiety

E.01.01 Prescribing for unlicensed applications

1673 – Evaluation of sleep and pain in newly diagnosed patients with generalised anxiety disorder (GAD): the espiga study

Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service

Veterinary surgeons and suicide: a structured review of possible influences on increased risk

P.4.a.009 Symptom improvement and functional recovery in patients with anxiety disorders

P.4.b.005 Impaired attentional control in high and low anxious healthy volunteers: evidence from the antisaccade task

Effects of mindfulness-based interventions on symptoms and interoception in trauma-related disorders and exposure to traumatic events: Systematic review and meta-analysis

Suchergebnisse filtern